Founder and CEO
JoAnn is a seasoned executive with extensive expertise in advising senior management on defining product development strategies and leading the execution of those strategies. She specializes in building high-performance development teams and ensuring milestones are met. Ms. Giannone has over 25 years' experience effectively leading companies through the drug and medical device development process. Prior to founding CSTI, Ms. Giannone, held leadership positions with Johnson & Johnson (RW Johnson Research institute) and Pharmacia.
Roger Nolan, Ph.D.
Roger provides scientific consult in the design of development plans and advice on investor relationships. He brings over 25 years of drug development experience to CSTI, having founded, lead, and advised pharmaceutical companies, managed several drug development programs, and led early stage fund-raising efforts. In addition to his role at CSTI, Dr. Nolan is co-founder, COO,and board member at BioKier. Formerly, Dr. Nolan held positions of increasing responsibility at Insmed Pharmaceucticals, Cato Research, and Calvert Research.